Coronary recanalization in acute myocardial infarction: immediate results and potential risks

• Serruys, P.W.J.C.
• Brand, M.J.B.M. van den
• Hooghoudt, T.E.H.
• Simoons, M.L.
• Fioretti, P.M.
• Ruiter, J.
• Fels, P.W.
• Hugenholtz, P.G.
• , et al.

January 1982
Article

Related Files
View PDF Version (1055.pdf, 8.4MB)

• Male
• Human
• Adult
• Middle Aged
• Clinical Trials
• 21829-25-4 (Nifedipine)
• Heart Catheterization
• EC 3.4.- (Streptokinase)
• Coronary Vessels
• 55-63-0 (Nitroglycerin)
• EC 3.4.21.73 (Urinary Plasminogen Activator)
• Fibrinolysis
• Nifedipine/therapeutic use
• Nitroglycerin/therapeutic use
• Pilot Projects
• Random Allocation
• 0 (Fibrinolytic Agents)
• Fibrinolytic Agents/administration & dosage/*therapeutic use
• Risk
• Myocardial Infarction/*drug therapy
• Streptokinase/administration & dosage/therapeutic use
• Urinary Plasminogen Activator/administration & dosage/therapeutic use